Skip to main content
. 2015 Mar 20;5:9344. doi: 10.1038/srep09344

Figure 1. Structure-activity relationship analysis of ESI-09.

Figure 1

(A). Chemical structure of ESI-09 and its analogs based on the core structure of 2-(5-(tert-butyl)isoxazol-3-yl)-2-oxo-N-phenyl- acetohydrazonoyl cyanide. (B) Dose-dependent competition of cAMP and ESI-09 analogs with 8-NBD-cAMP in binding to EPAC2.